Lipo-Med System is intended for use in the harvesting through liposuction, closed-loop processing, concentrating, and subsequent re-injection in different human body districts of autologous adipose tissue during the same surgery.
Autologous adipose tissue is rich in mesenchymal stem cells that can be used in different clinical applications, including orthopaedic surgery, arthroscopic surgery, wound healing, plastics and reconstructive surgery.
Lipo-Med System is provided SINGLE USE and STERILE.
Stem cells were first described in 1908 but were not studied until the 1960s [1].
In 2001 the adipose-derived stem cells was identified in mesenchyme stem cells similar to those found in bone marrow but easier to obtain and available in greater volumes [2].
[1] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3217290/
[2] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5679280/
LSM-Med is a fast-growing company engaged in developing, manufacturing and commercialising innovative medical solutions made from standard metallic and alternative material in the area of traumatology and foot surgery.